Skip to main content
Equibles

GLOBEFLEX CAPITAL L P

Position in EXEL — Exelixis, Inc.

CIK 921531 SAN DIEGO, CA
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$13,874,169
+$2,692,489 QoQ
Shares Held
254,993
-2.2% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
1.80%
of 13F equity value
Holder Rank
#116
of 757 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 92% Shared 0% None 8%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GLOBEFLEX CAPITAL L P holds $30,619,322 across 13 Biotechnology names. EXEL ranks #1 (45.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
This page 		254,993 $13,874,169
2 RIGL
Rigel Pharmaceuticals Inc
 112,672 $4,407,728
3 PBYI
Puma Biotechnology, Inc.
 382,807 $3,104,564
4 ZVRA
Zevra Therapeutics, Inc.
 191,904 $2,751,903
5 JAZZ
Jazz Pharmaceuticals plc
 10,645 $2,565,125
6 AGEN
Agenus Inc
 418,581 $1,280,857
7 INCY
Incyte Corp
 8,654 $981,017
8 ARVN
Arvinas, Inc.
 59,331 $493,040

All Filings in EXEL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,874,169 254,993
2026-03-31 $11,181,680 260,706
2025-12-31 $11,426,743 260,706
2025-09-30 $10,767,157 260,706
2025-06-30 $41,193,465 934,516
2025-03-31 $34,221,221 926,902
2024-12-31 $32,472,528 975,151
2024-09-30 $8,328,678 320,951
2024-06-30 $4,891,179 217,676
2024-03-31 $4,999,341 210,676
2023-12-31 $5,054,117 210,676
2023-09-30 $4,886,949 223,659
2023-06-30 $2,168,851 113,493
2023-03-31 $2,113,613 108,893
2022-12-31 $1,746,643 108,893
2022-09-30 $2,021,355 128,913
2022-06-30 $644,087 30,936
2022-03-31 $701,319 30,936
2021-12-31 $565,510 30,936
2021-09-30 $924,452 43,730
2021-06-30 $796,760 43,730
2021-03-31 $987,860 43,730
2020-09-30 $1,015,775 41,545
2020-06-30 $1,265,009 53,286
2020-03-31 $1,179,225 68,480